An Injectable in Situ Lipid Phase Transition System for Sustained Delivery of Dabigatran Etexilate With Low Burst Release

RSC Advances - United Kingdom
doi 10.1039/c7ra10375a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

An Injectable and in Situ-Gelling Biopolymer for Sustained Drug Release Following Perineural Administration

Spine
OrthopedicsNeurologySports MedicineSports Science
2008English

New Options With Dabigatran Etexilate in Anticoagulant Therapy

Vascular Health and Risk Management
2010English

Local Sustained Delivery of Oncolytic Adenovirus With Injectable Alginate Gel for Cancer Virotherapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2013English

Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need?

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2009English

Formulation of an Insitu Forming Injectable Sustained Release Sponge of Granisetron Hydrochloride

Journal of Drug Delivery and Therapeutics
2016English

Two and Half Years With Dabigatran Etexilate in Neurological Units

Journal of Vascular Medicine & Surgery
2013English

An Unusual Side Effect of Dabigatran Etexilate Use - Acute Renal Failure

Eurasian Journal of Emergency Medicine
2019English

Self-Sustained Potential Oscillations and the Main Phase Transition of Lipid Bilayers

Biophysical Journal
Biophysics
1993English

Injectable Polypeptide Hydrogel Depot System for Assessment of the Immune Response–Inducing Efficacy of Sustained Antigen Release Alone

Macromolecular Bioscience
PlasticsPolymersMaterials ChemistryBiomaterialsBioengineeringBiotechnology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy